FDA approves new abortion pill from company seeking to ‘normalize abortion’

 

The FDA approved a new abortion pill this week made by a company seeking to “normalize abortion.” / Credit: Postmodern Studio/Shutterstock

CNA Staff, Oct 2, 2025 / 16:13 pm (CNA).

The U.S. Food and Drug Administration (FDA) this week approved a new abortion pill made by a company that explicitly says it seeks to “normalize” abortion.

A Sept. 30 letter obtained from the office of Sen. Josh Hawley, R-Missouri, said the FDA approved the abbreviated new drug application for “mifepristone tablets” from Evita Solutions, a Virginia-based pharmaceutical company.

The FDA said in the letter that it had “concluded that adequate information has been presented to demonstrate that the drug meets the requirements for approval” under the Federal Food, Drug, and Cosmetic Act.

On its website as of Oct. 2, Evita Solutions was advertising a “new generic mifepristone product” coming to the U.S. Mifepristone constitutes one of the major components of abortion pill prescriptions.

The company says it “assist[s] the medical community in recognizing the utility and freedom that medical abortion provides patients.”

“[W]e seek to normalize abortion care, and we commit to making care accessible to all,” it says.

Evita Solutions did not immediately respond to a request for comment on Oct. 2. The drug’s approval, meanwhile, was met with criticism and pushback from pro-life advocates.

In an X post, Hawley called the approval “shocking.”

He wrote that the approval came “when the evidence shows chemical abortion drugs are dangerous and even deadly for the mother. And of course 100% lethal to the child.”

Marjorie Dannenfelser, the president of Susan B. Anthony Pro-Life America, said in a media statement that the “reckless” approval by the FDA was “unconscionable.”

“These dangerous drugs take the lives of unborn children, place women and underage girls at serious risk, empower abusers, and trample the pro-life laws enacted by states across the nation,” she said.

Kristan Hawkins, the president of Students for Life of America, said in a statement that the Trump administration’s approval of the drug “represents a true failure.”

“More babies will die; more women will be harmed; and more Americans [will be] exposed to abortion water pollution as a direct result of this unfathomable decision,” she said. “This is a stain on the Trump presidency and another sign that the deep state at the FDA must go.”


If you value the news and views Catholic World Report provides, please consider donating to support our efforts. Your contribution will help us continue to make CWR available to all readers worldwide for free, without a subscription. Thank you for your generosity!

Click here for more information on donating to CWR. Click here to sign up for our newsletter.


About Catholic News Agency 15446 Articles
Catholic News Agency (www.catholicnewsagency.com)

Be the first to comment

Leave a Reply

Your email address will not be published.

All comments posted at Catholic World Report are moderated. While vigorous debate is welcome and encouraged, please note that in the interest of maintaining a civilized and helpful level of discussion, comments containing obscene language or personal attacks—or those that are deemed by the editors to be needlessly combative or inflammatory—will not be published. Thank you.


*